DJIA 18,269.60 -16.14 -0.09%
NASDAQ 5,101.21 10.42 0.20%
S&P 500 2,129.57 -1.25 -0.06%
market minute promo

Novartis (NYSE: NVS)

104.35 -0.44 (-0.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $104.37 -0.40%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $103.95
Previous Close $104.79
Daily Range $103.81 - $104.25
52-Week Range $84.17 - $105.82
Market Cap $250.3B
P/E Ratio 28.32
Dividend (Yield) $2.67 (2.2%)
Ex-Dividend Date
Dividend Pay Date
03/02/15
04/20/15
Volume 177,797
Average Daily Volume 1,234,674
Current FY EPS $5.24

Sector

Healthcare

Industry

Drug Makers

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

Could This Be Healthcare's $158 Billion Black Swan Event?

This unlikely event is becoming increasingly more likely -- and the impact would be enormous.

Novartis Reports Two Positive US Phase III Programs in COPD for QVA149, NVA237

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 21, 2015

Biosimilars Vs Generics: History Does Not Repeat, It Rhymes

2 Stocks With Jaw-Dropping Growth Potential

These 2 companies are high-risk investments, but they nonetheless have the potential to become pivotal players in the rapidly expanding field of immuno-oncology. Here's why.

Baxter Takes The Acquisition Route To Grow In The Oncology Segment

Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for May 15, 2015

8 Top Healthcare Stocks to Watch

Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2015

Ligand Pharmaceuticals Tops Q1 Earnings, Affirms View - Analyst Blog

Ligand Pharmaceuticals Tops Q1 Earnings, Affirms View - Analyst Blog

See More NVS News...

NVS's Top Competitors

NVS $104.35 (-0.42%)
Current stock: NVS
JNJ $101.99 (-0.42%)
Current stock: JNJ
PFE $34.40 (0.10%)
Current stock: PFE
MRK $59.75 (-0.58%)
Current stock: MRK